We are live on ! Find out more
FVCM

F&V Capital Management Portfolio holdings

AUM $542M
1-Year Est. Return 46.38%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+46.38%
3 Year Est. Return
+107.45%
5 Year Est. Return
+141.57%
10 Year Est. Return
+523.33%
AUM
$125M
AUM Growth
+$7.46M
Cap. Flow
-$4.64M
Cap. Flow %
-3.7%
Top 10 Hldgs %
37.72%
Holding
69
New
4
Increased
25
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$2.2M
2
HIG icon
Hartford Financial Services
HIG
+$1.79M
3
TQNT
TRIQUINT SEMICONDUCTOR INC
TQNT
+$1.63M
4
CELG
Celgene Corp
CELG
+$1.14M
5
DTD icon
WisdomTree US Total Dividend Fund
DTD
+$284K

Top Sells

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$2.68M
2
YHOO
Yahoo Inc
YHOO
+$2.62M
3
FDX icon
FedEx
FDX
+$1.78M
4
HES
Hess
HES
+$1.41M
5
MS icon
Morgan Stanley
MS
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 15.35%
2 Consumer Discretionary 14.39%
3 Energy 12.92%
4 Technology 12.23%
5 Financials 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TPR icon
51
Tapestry
TPR
$30.3B
$363K 0.29%
6,480
-49,565
-88% -$2.68M
FCX icon
52
Freeport-McMoran
FCX
$86.2B
$343K 0.27%
9,105
-716
-7% -$25.4K
PEP icon
53
PepsiCo
PEP
$196B
$342K 0.27%
4,125
– –
PM icon
54
Philip Morris
PM
$309B
$323K 0.26%
3,710
-50
-1% -$4.37K
NE
55
DELISTED
Noble Corporation
NE
$288K 0.23%
8,807
-291
-3% -$9.66K
SLB icon
56
SLB Ltd
SLB
$72.7B
$243K 0.19%
2,697
-860
-24% -$77.6K
SCZ icon
57
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
$208K 0.17%
+4,095
New +$203K
VIVS
58
VivoSim Labs
VIVS
$1.21M
$125K 0.1%
47
-21
-31% -$41.2K
HIX
59
Western Asset High Income Fund II
HIX
$347M
$123K 0.1%
13,637
-10,000
-42% -$92.2K
OCZ
60
DELISTED
OCZ TECHNOLOGY GROUP INC COM STK NEW (DE)
OCZ
$1K ﹤0.01%
17,000
-5,000
-23% -$3.58K
BPT
61
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
– –
-2,600
Closed -$225K
CVE icon
62
Cenovus Energy
CVE
$54.2B
– –
-8,235
Closed -$245K
EWJ icon
63
iShares MSCI Japan ETF
EWJ
$21.2B
– –
-3,525
Closed -$168K
EWZ icon
64
iShares MSCI Brazil ETF
EWZ
$8.98B
– –
-4,450
Closed -$213K
MAG
65
DELISTED
MAG Silver
MAG
– –
-20,000
Closed -$117K
TEVA icon
66
Teva Pharmaceuticals
TEVA
$40.4B
– –
-13,486
Closed -$509K
TGNA
67
DELISTED
TEGNA Inc
TGNA
– –
-33,901
Closed -$475K
WGO icon
68
Winnebago Industries
WGO
$900M
– –
-15,620
Closed -$405K
NES
69
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
– –
-1,500
Closed -$34K
1 2
3

Similar funds

BCB
Brian C. Broderick $542M AUM 20.28% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return
WW
Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

F&V Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, F&V Capital Management held 69 positions worth $125M, up 6.3% from $118M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

F&V Capital Management withdrew a net $4.64M in Q4 2013, closing 9 positions and reducing 26 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $509K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, F&V Capital Management opened a new position in Expedia Group worth $2.6M.

  • F&V Capital Management's largest Q4 2013 buy was Expedia Group: 37,325 shares worth $2.6M.
  • F&V Capital Management added most to Celgene Corp in Q4 2013, an estimated $1.14M increase.
  • F&V Capital Management's biggest Q4 2013 reduction was Tapestry, cutting an estimated $2.68M.
  • F&V Capital Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $509K.
  • F&V Capital Management's ten largest holdings make up 38% of its $125M portfolio in Q4 2013.
  • F&V Capital Management opened 4 new positions and closed 9 in Q4 2013.
  • F&V Capital Management's portfolio value rose 6.3% quarter-over-quarter to $125M.

Based on F&V Capital Management's 13F filing for Q4 2013, filed 5 Feb 2014.